U.S. Physical Therapy Inc... (USPH)
NYSE: USPH
· Real-Time Price · USD
85.68
-0.13 (-0.15%)
At close: Sep 05, 2025, 3:59 PM
85.64
-0.05%
After-hours: Sep 05, 2025, 05:29 PM EDT
U.S. Physical Therapy Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Patient Revenues Revenue | 164.18M | 152.55M | 150.06M | 139.15M | 140.27M | 131.07M | 258.69M | 127.24M | 129.28M | 126.58M | 120.15M | 116.71M | 118.2M | 109.54M | 113.51M | 112.33M | 113.24M | 99.25M | 104.54M | 96.4M | 72.28M | 100.13M | 108.94M | 104.39M | 113.36M | 106.65M | 107.81M | 103.35M | 105.99M | 100.55M |
| Net Patient Revenues Revenue Growth | +7.63% | +1.66% | +7.84% | -0.80% | +7.02% | -49.33% | +103.31% | -1.58% | +2.13% | +5.36% | +2.94% | -1.26% | +7.90% | -3.50% | +1.05% | -0.80% | +14.09% | -5.05% | +8.44% | +33.37% | -27.81% | -8.09% | +4.36% | -7.91% | +6.29% | -1.07% | +4.31% | -2.49% | +5.41% | n/a |
| Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue | 33.16M | 31.24M | 30.39M | 28.89M | 26.92M | 24.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue Growth | +6.15% | +2.81% | +5.19% | +7.31% | +9.43% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 16.25M | 15.57M | 14.38M | 11.45M | 15.71M | 11.36M | 9.61M | 12.14M | 13.86M | 11.93M | 11.89M | 10.74M | 11.56M | 10.72M | 12.87M | 12.07M | 10.87M | 10.92M | 10.42M | 9.02M | 11.68M | 11.67M | 10.56M | 11.53M | 11.29M | 10.41M | 10.64M | 10.13M | 10.16M | 10.18M | 8.3M | 8.86M | 8.55M | 7.84M | 7.61M | 8.03M | 9M | 8.89M | 6.92M | 7.59M | 7.66M |
| Selling, General, and Administrative Revenue Growth | -100.00% | +4.33% | +8.24% | +25.61% | -27.11% | +38.31% | +18.26% | -20.91% | -12.37% | +16.22% | +0.30% | +10.69% | -7.05% | +7.82% | -16.70% | +6.57% | +11.04% | -0.38% | +4.74% | +15.52% | -22.74% | +0.03% | +10.58% | -8.42% | +2.07% | +8.43% | -2.14% | +5.08% | -0.34% | -0.19% | +22.62% | -6.23% | +3.62% | +9.03% | +3.01% | -5.18% | -10.86% | +1.24% | +28.47% | -8.82% | -0.84% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |